Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the newcastle disease virus fusion protein

Journal of Virology

Volumn 75, Issue 17, 2001, Pages 7934-7943

  Sergel, T A ^a   McGinnes, L W ^a   Morrison, T G ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MUTANT PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; CENTRIFUGATION, DENSITY GRADIENT; CERCOPITHECUS AETHIOPS; COS CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; MOLECULAR SEQUENCE DATA; MUTATION; NEWCASTLE DISEASE VIRUS; PEPTIDES; PROTEIN FOLDING; VIRAL FUSION PROTEINS;

EID: 0034877974     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.17.7934-7943.2001     Document Type: Article

References (43)

1. Quantitative measurement of paramyxovirus fusion: Differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus
2. Structural basis for paramyxovirus-mediated membrane fusion Mol
3. Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum
4. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion
5. Structure of influenza haemagglutinin at the pH of membrane fusion
6. A spring loaded mechanism for the conformational change of influenza hemagglutinin
7. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins
8. HIV entry and its inhibition
9. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion
10. Capture of an early fusion-active conformation of HIV-1 gp41
11. Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion
12. Virus-cell and cell-cell fusion
13. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion
14. Activation of the Sendai virus fusion protein (F) involves a conformational change with exposure of a new hydrophobic region
15. A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41
16. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion
17. GPI- and transmembrane anchored influenza hemagglutinin differ in structure and receptor binding activity
18. Paramyxoviridae: The viruses and their replication
19. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion
20. Heptad repeat regions of respiratory syncytial virus F(1) protein form a six membered coiled-coil complex
21. Effect of cleavage mutants on syncytium formation directed by the wild-type fusion protein of Newcastle disease virus
22. The core of the respiratory syncytial virus fusion protein is a trimeric, coiled coil
23. Structural rearrangements in the transmembrane glycoprotein after receptor binding
24. Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity
25. Fusogenic mechanisms of enveloped virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell-dependent reporter gene activation
26. Paramyxovirus F1 protein has two fusion peptides: Implications for the mechanism of membrane fusion
27. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses
28. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein
29. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity
30. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation
31. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion
32. Atomic structure of a thermostable subdomain of the HIV-1 gp41
33. Membrane glycoprotein folding, oligomerization, and intracellular transport: Effects of dithiothreitol in living cells
34. Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 Amino acid substitutions in position "d."
35. De novo design of a model peptide sequence to examine the effects of single amino acid substitutions in the hydrophobic core on both stability and oligomerization state of coiled-coils
36. The role of position "a" in determining the stability and oligomerization state of alpha-helical coiled coils: 20 Amino acid stability coefficients in the hydrophobic core of proteins
37. Intracellular processing of the paramyxovirus F protein: Critical role of the predicted amphipathic alpha helix adjacent to the fusion domain
38. Atomic structure of the ectodomain from HIV-1 gp-41
39. Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein
40. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection
41. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling
42. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions
43. Structural characterization of the human respiratory syncytial virus fusion protein core